2436-2437 / 2953
Conclusions
•
The benefits of EBRT can be enhanced by dose
escalation:
Improves biochemical and/or clinical failure in localized or
locally advanced PCa, with acceptable genitourinary and
rectal safety
1-
56
56
•
The benefit of adding ADT to RT is established
The exact timing and duration of ADT is still under investigation
It remains to be established whether combining these
approaches improves Prostate Cancer outcomes further
1. Aral IA et al.
www.emedicine.medscape.com/article/454283-overview;2.
Heidenreich A et al. EAU guidelines 2012; 3. Pinkawa M et al. Strahlenther Onkol 2011;187:479–484;
4. Payne H, Mason M Br J Cancer 2011;105):1628-34; 5. Smith MJ et al. Prostate Cancer 2012; article ID 280278 Epub 2012